论文部分内容阅读
本组资料提示癌瘤局部淋巴结的免疫形态学改变,可以反映各个淋巴结本身防止癌转移的能力,其细胞免疫反应型和一般免疫反应型愈明显,癌转移发生率愈低,而体液免疫反应型似有助癌转移形成的趋势。各主导型的情况与各相应类型的一致,即细胞免疫反应主导型和一般免疫反应主导型者不易发生转移癌,而体液免疫反应主导型和免疫不良反应主导型者,则易现转移癌。细胞免疫反应主导型,一般免疫反应主导型和细胞免疫反应型明显者的五年存活例数稍多一些,而体液免疫反应主导型,免疫不良反应主导型和体液免疫反应型明显者的五年存活例数。则略少一些。
The data in this group suggest that the immunohistochemical changes in the local lymph nodes of cancerous tumors can reflect the ability of each lymph node itself to prevent cancer metastasis. The more obvious the cellular immune response type and the general immune response type, the lower the incidence of cancer metastasis, and the humoral immune response type. It seems to help the formation of cancer metastasis. The dominant conditions are consistent with the corresponding types, ie those with a dominant cellular immune response and those with a dominant immune response are less likely to develop metastatic cancer, whereas those with a dominant humoral immune response and a dominant immunocompromised response are more likely to have metastatic cancer. The five-year surviving cases with dominant cell immune response, dominant immune response and obvious cellular immune response were slightly more than five years, while those with dominant humoral immune response, dominant immune response and humoral immune response were five years old. Number of surviving cases. Slightly less.